2730-LB: Macrophage GIPR Promotes Diabetic Wound Healing via AMPK–Mitochondrial Axis
Diabetes · 05.06.2026 · 75 (Supplement_1)
DOI: 10.2337/db26-2730-lb ↗Kurz gefasst
Fachartikel in der Zeitschrift Diabetes, erschienen am 05.06.2026. Verfasst von YIFAN TU und 1 weiteren Autor:innen.
Themen: Wundversorgung
Abstract (Originalsprache)
Introduction and Objective: GIPR is a novel metabolic drug target, yet its role in dermal macrophages (DMs) during diabetic wound healing is unknown. We studied whether DM GIPR regulates diabetic wound via metabolic reprogramming.
Methods
Myeloid GIPR KO and controls received STZ, then excisional wounds. Closure, CD31/collagen, M1/M2 markers and ROS were measured. DMs underwent RNA-seq, Seahorse, JC-1 and WB to assess metabolic profiles. Local AMPK agonist EX229 was delivered for therapy.
Results
GIPR KO delayed diabetic wound closure, reduced angiogenesis and collagen, and increased inflammation. KO DMs were M1-biased with higher ROS. RNAseq, seahorse and JC-1 showed suppression of AMPK and OXPHOS. WB showed reduced p-AMPK. Local EX229 restored M2 features and rescued healing.
Conclusion
DM GIPR sustains AMPK-mitochondrial homeostasis in diabetic repair. AMPK activation is a new potential therapy. Disclosure Y. Tu: None. C. Zheng: None.
Zitieren
APA
TU, Y., & ZHENG, C. (2026). 2730-LB: Macrophage GIPR Promotes Diabetic Wound Healing via AMPK–Mitochondrial Axis. Diabetes, 75(Supplement_1). https://doi.org/10.2337/db26-2730-lb
Vancouver
TU Y, ZHENG C. 2730-LB: Macrophage GIPR Promotes Diabetic Wound Healing via AMPK–Mitochondrial Axis. Diabetes. 2026;75(Supplement_1). doi:10.2337/db26-2730-lb
BibTeX
@article{TU2026,
author = {TU, YIFAN and ZHENG, CHAO},
title = {2730-LB: Macrophage GIPR Promotes Diabetic Wound Healing via AMPK–Mitochondrial Axis},
journal = {Diabetes},
year = {2026},
volume = {75},
number = {Supplement_1},
doi = {10.2337/db26-2730-lb}
}
EUVIMED